Glutathione-responsive homodithiacalix[4]arene-based nanoparticles for selective intracellular drug delivery.
Glutathione-responsive, paclitaxel-loaded nanoparticles based on homodithiacalix[4]arene were successfully developed, exhibiting selective drug release in cancer cells.